VIVITROL

VIVITROL is a prescription medicine brand offering extended-release injectable naltrexone for adults receiving treatment for alcohol dependence or opioid dependence. Administered by a healthcare provider as a once-monthly injection, it is intended to support recovery alongside counseling and other alcohol or drug recovery programs. For alcohol dependence, patients should stop drinking before starting treatment; for opioid dependence, VIVITROL is used to help prevent relapse after opioid detoxification, and patients must stop taking opioids before treatment begins.

The brand’s website provides educational resources about addiction and dependence, patient stories, guidance for discussing treatment with a healthcare provider, and tools to find a provider. It also offers information about insurance coverage and a co-pay savings program for eligible patients. VIVITROL is not suitable for everyone and carries significant risks, including opioid overdose, sudden withdrawal, serious injection-site reactions, and liver problems.

The site encourages patients to review the Medication Guide and prescribing information and discuss benefits and risks with a healthcare provider